Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lomtegovimab (BI 767551), a humanized monoclonal antibody targeting the SARS-CoV-2 spike glycoprotein, exhibits antiviral efficacy by binding to and neutralizing the virus. This compound holds potential for COVID-19 research [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Lomtegovimab (BI 767551), a humanized monoclonal antibody targeting the SARS-CoV-2 spike glycoprotein, exhibits antiviral efficacy by binding to and neutralizing the virus. This compound holds potential for COVID-19 research [1] [2]. |
Molecular Weight | N/A |
CAS No. | 2550869-33-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lomtegovimab 2550869-33-3 inhibitor inhibit